Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Mark W. Watson Net Worth & Insider Trades

Mark W. Watson - Director, Hedgepath Pharmaceuticals, Inc

As of September 9, 2014

What is Mark W. Watson's Net Worth?

The current estimated net worth of Hedgepath Pharmaceuticals, Inc's Director, Mark W. Watson, is estimated to be about $661.09K . Mark W. Watson owns about 10,000 units of Hedgepath Pharmaceuticals, Inc common stock. Recently at Hedgepath Pharmaceuticals, Inc, Mark W. Watson has sold an estimated value of $0 worth.

What is Mark W. Watson's Past Insider Trading?

Mark W. Watson's largest purchase order was 10,000 units , worth over $1.3K on September 9, 2014. In total, Mark W. Watson has made about 1 transaction recently at Hedgepath Pharmaceuticals, Inc. Mark W. Watson usually trades in September, with the busiest year in 2014.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

W. Mark Watson

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What was Mark W. Watson's Salary in 2020?

As Director of Hedgepath Pharmaceuticals, Inc, Mark W. Watson has a total base salary of $231,965 . Mark W. Watson received compensation valued at about $2,844,828 in 2020 after becoming Director.

What is Mark W. Watson's' Mailing Address?

  • Mailing address is 324 S. Hyde Park Avenue Ste 350 Tampa FL 33606 FL

What are Hedgepath Pharmaceuticals, Inc's Past Insider Trades?

Hedgepath Pharmaceuticals, Inc's most recent insider trade came on August 31, 2018 by Garrison J Hasara who sold 100,000 units worth $27K . In the last 4 years, insiders at Hedgepath Pharmaceuticals, Inc have sold an estimated value of $3.56M and bought an estimated value of $2.16M worth of shares. Insider trading is most common in March, with the busiest year in 2018. The most active traders at the company are Mayne Pharma Group Ltd,  Mayne Pharma International Pty Ltd,  and Mayne Pharma Ventures Pty Ltd .

HedgePath Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...